Imaging immune cells and glutamate activity in the brain

Real time imaging of immune cells and glutamate dynamics by PET and metabolic MRI

NIH-funded research Washington University · NIH-10933007

This study is looking at how certain immune cells and a brain chemical called glutamate affect the progression of multiple sclerosis, using special imaging techniques to help us see what's happening in real-time, which could lead to better treatments for patients like you.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University NIH-funded
Lab location1 site (Saint Louis, United States)
Project IDNIH-10933007 on NIH RePORTER

What this research studies

This research investigates how immune cell activation and glutamate dynamics contribute to the progression of multiple sclerosis (MS). By utilizing advanced imaging techniques like PET and metabolic MRI, the study aims to visualize immune responses and glutamate metabolism in real-time. This approach could enhance our understanding of MS pathogenesis and improve monitoring of treatment responses. Patients may benefit from insights gained through noninvasive imaging methods that could lead to better therapeutic strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with multiple sclerosis who are experiencing disease progression.

Not a fit: Patients with other neurological conditions unrelated to multiple sclerosis may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic and treatment options for patients with multiple sclerosis.

How similar studies have performed: Previous research has shown promise in using similar imaging techniques to study immune responses and metabolic processes in various diseases.

Where this research is happening

Saint Louis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Amyotrophic Lateral Sclerosis Motor Neuron Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.